Genetic Risk Factors for Superficial Vein Thrombosis

Summary

Inherited thrombophilic states are associated with an increased risk for deep vein thrombosis (DVT), but whether they are also risk factors for superficial vein thrombosis (SVT) is uncertain. We assessed the risk conferred by inherited thrombophilic states in patients with a first episode of SVT in whom the coexistence of DVT had been ruled out by ultrasonography. Sixty-three patients with SVT, after exclusion of patients with varicose veins, malignant or autoimmune disease, and 537 healthy individuals were investigated. The G1691A mutation in the factor V gene, the G20210A mutation in the prothrombin gene, and deficiencies of the naturally occurring inhibitors of coagulation (antithrombin, protein C, protein S) were searched. The prevalence of each thrombophilic state was higher in patients than in controls. The odds ratios for SVT were 6.1 (95% confidence interval [CI], 2.6 to 14.2) in patients with the G1691A factor V mutation, 4.3 (95% CI, 1.5 to 12.6) in those with the G20210A prothrombin mutation, and 12.9 (95% CI, 3.6 to 46.2) in those with deficiencies of the naturally occurring inhibitors of coagulation taken together. Risks did not substantially change when the analysis was restricted to 43 patients who had SVT as their only thrombotic manifestation, being 4.3 (95% CI, 1.5 to 12.3) in patients with factor V mutation, and 3.6 (95% CI, 1.0 to 13.1) in those with the prothrombin mutation. Among the circumstantial risk factors investigated (surgery, trauma, prolonged immobilization, oral contraceptives and pregnancy or puerperium), pregnancy or puerperium was the most frequently associated with SVT, being present in 38% of women. Our findings indicate that inherited thrombophilic states are associated with an increased risk for SVT. Hence, a laboratory search of these alterations is recommended in patients with SVT, because it allows the identification of patients at high risk of DVT in whom antithrombotic prophylaxis is particularly warranted.

• References

• 1 Bounameaux H, Reber-Wasem MA. Superficial vein thrombophlebitis and deep vein thrombosis. Arch Intern Med 1997; 157: 1822-4.
• 2 Bergquist D, Jaroszewski H. Deep vein thrombosis in patients with superficial thrombophlebitis of the leg. Br Med J 1985; 292: 658-9.
• 3 Skillman JJ, Kent KC, Porter DH, Kim D. Simultaneous occurrence of superficial and deep thrombophlebitis in the lower extremity. J Vasc Surg 1990; 11: 818-23.
• 4 Jorgensen JO, Hanel KC, Morgan AM, Hunt JM. The incidence of deep venous thrombosis in patients with superficial thrombophlebitis of the lower limbs. J Vasc Surg 1993; 18: 703.
• 5 Chengelis DL, Bendick PJ, Glover JL, Brown OW, Ranval TJ. Progression of superficial venous thrombosis to deep vein thrombosis. J Vasc Surg 1996; 24: 745-9.
• 6 Blattler W, Frick E. Complications of superficial thrombophlebitis. Schweiz Med Wochenschr 1993; 123: 223-8.
• 7 De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996; 87: 3531-4.
• 8 Poort SR, Rosendaal FR, Reitsma PH, Bertina RM. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698-703.
• 9 Broekmans AW, Conard J. Hereditary protein C deficiency. in: Bertina RM. (ed) Protein C and related proteins. Edinburgh, UK: Churchill Livingstone: 1988: 160.
• 10 Briët E, Broekmans AW, Engesser L. Hereditary protein S deficiency. in: Bertina RM. (ed): Protein C and related proteins. Edinburgh, UK: Churchill Livingstone; 1988: 203.
• 11 De Stefano V, Leone G, Mastrangelo S. et al. Clinical manifestations and management of inherited thrombophilia: retrospective analysis and follow-up after diagnosis in 238 patients with congenital deficiency of antithrombin III, protein C or protein S. Thromb Haemost 1994; 72: 352-8.
• 12 Martinelli I, Mannucci PM, De Stefano V, Taioli E, Rossi V, Crosti F, Paciaroni K, Leone G, Faioni EM. Different risks of thrombosis in four coagulation defects associated with inherited thrombophilia. A study of 150 families. Blood 1998; 92: 2353-8.
• 13 de Moerloose P, Wutschert R, Heinzmann M, Perneger T, Reber G, Bounameaux H. Superficial vein thrombosis of lower limbs: influence of factor V Leiden, factor II G20210A and overweight. Thromb Haemost 1998; 80: 239-41.
• 14 Thomas DP. Pathogenesis of venous thrombosis. in Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD. (eds): Hemostasis and Thrombosis. Third edition. Churchill Livingstone; 1994: 1335-47.
• 15 Lutter KS, Rerr TM, Roedersheimer R, Lohr JM, Sampson MG, Cranley JJ. Superficial thrombophlebitis diagnosed by duplex scanning. Surgery 1991; 100: 42-6.
• 16 Frezzato M, Tosetto A, Rodeghiero F. Validated questionnaire for the identification of previous personal or familial venous thromboembolism. Am J Epidemiol 1996; 143: 1257-65.
• 17 Bertina RM, Koeleman RPC, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
• 18 Poort SR, Bertina RM, Vos HL. Rapid detection of the prothrombin 20210 A variation by allele-specific PCR. Thromb Haemost 1997; 78: 1157-8.
• 19 Comp PC, Doray D, Patton D, Esmon CT. An abnormal plasma distribution of protein S occurs in functional protein S deficiency. Blood 1986; 67: 504-8.
• 20 SAS user’s guide, version 6. 4th ed.. Cary, NC: SAS Institute; 1990